News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ignelzi Troy A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 80 shares
@ $173.64, valued at
$13.9k
Sold 855 shares
@ $174.88, valued at
$149.5k
Sold 505 shares
@ $175.59, valued at
$88.7k
Sold 60 shares
@ $176.6, valued at
$10.6k
Exercised 1,500 options to buy
@ $9.2, valued at
$13.8k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/25/2023 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 724 shares
@ $221.28, valued at
$160.2k
Sold 2,093 shares
@ $222.24, valued at
$465.1k
Sold 3,309 shares
@ $223.21, valued at
$738.6k
Sold 1,070 shares
@ $224.19, valued at
$239.9k
Sold 1,022 shares
@ $225.19, valued at
$230.1k
Sold 782 shares
@ $225.93, valued at
$176.7k
Exercised 9,000 options to buy
@ $9.2, valued at
$82.8k
|
|
| 05/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/24/2023 |
4
| Ignelzi Troy A. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 36,324 options to buy
@ $5.82, valued at
$211.4k
Disposed/sold 58,823 options to buy
@ $13.6, valued at
$800k
|
|
| 02/23/2023 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 6,000 shares
@ $190.01, valued at
$1.1M
Exercised 6,000 options to buy
@ $9.2, valued at
$55.2k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 817 shares
@ $201.41, valued at
$164.6k
Sold 200 shares
@ $200.14, valued at
$40k
Exercised 817 options to buy
@ $9.2, valued at
$7.5k
Exercised 200 options to buy
@ $9.2, valued at
$1.8k
|
|
| 12/19/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Exercised 10,869 options to buy
@ $9.2, valued at
$100k
Exercised 371 options to buy
@ $9.2, valued at
$3.4k
Exercised 627 options to buy
@ $9.2, valued at
$5.8k
|
|
| 11/17/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 16,500 shares
@ $225.85, valued at
$3.7M
Exercised 16,500 options to buy
@ $9.2, valued at
$151.8k
|
|
| 10/04/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,459 shares
@ $227.05, valued at
$558.3k
Sold 2,819 shares
@ $228.74, valued at
$644.8k
Sold 5,189 shares
@ $229.77, valued at
$1.2M
Sold 33 shares
@ $230.49, valued at
$7.6k
Sold 1,000 shares
@ $230.02, valued at
$230k
Sold 2,000 shares
@ $231.3, valued at
$462.6k
Sold 1,100 shares
@ $232, valued at
$255.2k
Sold 400 shares
@ $233.2, valued at
$93.3k
|
|
| 08/11/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 16,500 shares
@ $227.83, valued at
$3.8M
Exercised 16,500 options to buy
@ $9.2, valued at
$151.8k
|
|
| 04/21/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 3,500 shares
@ $130.81, valued at
$457.8k
Sold 704 shares
@ $133.2, valued at
$93.8k
Sold 40 shares
@ $134.46, valued at
$5.4k
Exercised 3,500 options to buy
@ $9.2, valued at
$32.2k
Exercised 704 options to buy
@ $9.2, valued at
$6.5k
Exercised 40 options to buy
@ $9.2, valued at
$368 |
|
| 02/17/2022 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 1,500 shares
@ $111.14, valued at
$166.7k
Exercised 1,500 options to buy
@ $9.2, valued at
$13.8k
Granted 48,500 options to buy
@ $111.97, valued at
$5.4M
|
|
| 01/06/2022 |
3
| Ignelzi Troy A. (Director) has filed a Form 3 on CinCor Pharma, Inc. |
| 12/22/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Exercised 5,869 options to buy
@ $9.2, valued at
$54k
Exercised 1,101 options to buy
@ $9.2, valued at
$10.1k
|
|
| 11/10/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 13,500 shares
@ $152.32, valued at
$2.1M
Exercised 13,500 options to buy
@ $9.2, valued at
$124.2k
|
|
| 09/10/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 7,000 shares
@ $116.16, valued at
$813.1k
Sold 600 shares
@ $121.01, valued at
$72.6k
Sold 500 shares
@ $120.05, valued at
$60k
Sold 1,900 shares
@ $120.05, valued at
$228.1k
Exercised 7,000 options to buy
@ $9.2, valued at
$64.4k
Exercised 600 options to buy
@ $9.2, valued at
$5.5k
Exercised 500 options to buy
@ $9.2, valued at
$4.6k
Exercised 1,900 options to buy
@ $9.2, valued at
$17.5k
|
|
| 08/23/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $9.2, valued at
$46k
|
|
| 06/16/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,248 shares
@ $129.45, valued at
$291k
Sold 900 shares
@ $132.52, valued at
$119.3k
Sold 352 shares
@ $128.4, valued at
$45.2k
Exercised 2,248 options to buy
@ $9.2, valued at
$20.7k
Exercised 900 options to buy
@ $9.2, valued at
$8.3k
Exercised 352 options to buy
@ $9.2, valued at
$3.2k
|
|
| 05/12/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 7,000 shares
@ $110.07, valued at
$770.5k
Sold 200 shares
@ $120, valued at
$24k
Exercised 7,000 options to buy
@ $9.2, valued at
$64.4k
Exercised 200 options to buy
@ $9.2, valued at
$1.8k
|
|
| 02/24/2021 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 51,650 options to buy
@ $131.64, valued at
$6.8M
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Exercised 5,869 options to buy
@ $9.2, valued at
$54k
Exercised 2,131 options to buy
@ $9.2, valued at
$19.6k
|
|
| 11/10/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 564 shares
@ $108.15, valued at
$61k
Sold 8,000 shares
@ $105.02, valued at
$840.2k
Sold 1,318 shares
@ $108.26, valued at
$142.7k
Sold 118 shares
@ $103.48, valued at
$12.2k
Exercised 564 options to buy
@ $9.2, valued at
$5.2k
Exercised 8,000 options to buy
@ $9.2, valued at
$73.6k
Exercised 1,318 options to buy
@ $9.2, valued at
$12.1k
Exercised 118 options to buy
@ $9.2, valued at
$1.1k
|
|
| 09/10/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $73.3, valued at
$146.6k
Exercised 2,000 options to buy
@ $9.2, valued at
$18.4k
|
|
| 08/27/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $9.2, valued at
$46k
|
|
| 07/10/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 6,000 shares
@ $98.32, valued at
$589.9k
Sold 2,000 shares
@ $100, valued at
$200k
Exercised 6,000 options to buy
@ $9.2, valued at
$55.2k
Exercised 2,000 options to buy
@ $9.2, valued at
$18.4k
|
|
| 06/17/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,000 shares
@ $90, valued at
$180k
Sold 4,000 shares
@ $89.62, valued at
$358.5k
Sold 2,000 shares
@ $100, valued at
$200k
Exercised 2,000 options to buy
@ $9.2, valued at
$18.4k
Exercised 4,000 options to buy
@ $9.2, valued at
$36.8k
Exercised 2,000 options to buy
@ $9.2, valued at
$18.4k
|
|
| 05/12/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $83.38, valued at
$625.4k
Exercised 7,500 options to buy
@ $9.2, valued at
$69k
|
|
| 03/04/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 7,500 shares
@ $86.5, valued at
$648.8k
Exercised 7,500 options to buy
@ $9.2, valued at
$69k
|
|
| 02/19/2020 |
4
| Ignelzi Troy A. (CFO) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $99.72, valued at
$5.5M
|
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|
|